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November 1998 with the explicit mission of working to
advance the elimination of trachoma and the blindness it
causes. A WHO-approved strategy called SAFE is simple,
sustainable, and addresses both cure and prevention:
Surgery for trichiasis—the immediate precursor to
blindness
Antibiotics to treat active disease
Facial cleanliness to reduce transmission
Environmental improvement to control the agents of the
disease
In ITI countries the antibiotic used is Zithromax
(azithromycin), donated by Pfizer. A single oral dose of
Zithromax once a year is as effective as the standard
treatment of tetracycline eye ointment 2 times a day for 6
weeks. The ITI is currently working in five countries:
Morocco, Tanzania, Mali, Ghana, and Vietnam. The ITI works
with ministries of health to devise an operating plan and joins
WHO, United Nations Children’s Fund, and nongovernmen-
tal organizations to carry out this work.
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In the 1960s, the United States began to lose interest in
public health.  The development of effective vaccines and
antibiotics, combined with the long-term benefits of
sanitary reforms begun 100 years earlier, fostered the
belief that communicable diseases had been conquered and
that it was time to focus the nation’s resources on chronic
diseases such as cancer and heart disease.  This shift led to
the deterioration of the public health infrastructure,
including public health law training and practice.  At the
same time, bioethics and the legal specialty of health law
began to evolve.  Both of these fields were individual-
centered: bioethics concentrated in individual autonomy and
health law concentrated on the delivery of, and reimburse-
ment for, personal health services.  By the 1980s, legal
discourse and training on health and public health was
dominated by an individual-centered jurisprudence that
subordinated the public’s interest to that of the individual.
Although this approach resulted in important advances in
patient autonomy, it undermined the public’s understand-
ing and acceptance of the traditional role of public health
law—the protection of the health of the population.  Many
states weakened their communicable disease-reporting
laws and otherwise made it more difficult to identify and
manage communicable disease threats.  More critically,
public health professionals began to believe that they do
not have the legal authority to restrict individual behavior
to protect the public health and that their role is to provide
personal health services on the same basis as private
health care providers.
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The threat of emerging infectious diseases and
bioterrorism is forcing the states and the federal government
to reassess the U.S. public health infrastructure and the
provision of public health services, as well as to review
international treaties and trade agreements to ensure that
they are consistent with effective public health measures.  As
part of this process, it is critical to ensure that each
jurisdiction has adequate legal authority to protect the health
of the public and to act quickly in the face of bioterrorism or a
disease outbreak.  This will require the restoration of more
traditional public health laws in some jurisdictions and the
training of lawyers, judges, and public health professionals in
public health jurisprudence.  The federal government should
help coordinate state efforts and should ensure that there are
no federal law impediments to effective public health
enforcement.
The restoration and expansion of the public health
infrastructure and the development of more effective public
health legal services will have many benefits beyond
improving the response to emerging infectious diseases and
bioterrorism.  Achieving these goals is also essential to the
improvement of the delivery of routine public health services
such as food sanitation, immunizations, and the abatement of
hazardous environmental conditions.
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